FDA Plans For Private-Payer Meetings Ahead, But Roadblocks Remain

FDA’s device center is recruiting private payers to meet with manufacturers during the pre-submission process to hasten reimbursement. But some experts believe the effort may be hobbled by a lack of common interests.